HIV trial under scrutiny
Wednesday, January 16, 2013 - 07:30
in Health & Medicine
Critics say that antibody therapy is too expensive for its African target population.Nature 493 279 doi: 10.1038/493279a
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via